[Lys5,MeLeu9,Nle10]-NKA(4-10)-1mg

Description

[Lys5,MeLeu9,Nle10]-NKA(4-10) is a highly selective and potent NK2 receptor agonist, with an IC50 of 6.1 nM[1].—COVID-19-immunoregulation–C39H65N9O9—-[1]G Chassaing, et al. Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay). Neuropeptides. 1991 Jun;19(2):91-5.|[2]M A Matuszek, et al. An investigation of tachykinin NK2 receptor subtypes in the rat. Eur J Pharmacol. 1998 Jul 3;352(1):103-9.–137565-28-7–803.99—-[DKFVG{N(Me)Leu}{Nle}-NH2]–Inflammation/Immunology–H2O–Neurokinin Receptor—-GPCR/G Protein;Neuronal Signaling–Peptides